Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis

Table 4 Mean (SD) health utility, Quality Adjusted Life Years (QALYs) and costs

	Control			Intervention
EQ-5D-3L	Baseline n = 103	12-week follow-up n = 79	Change n = 79	Baseline n = 103	12-week follow-up n = 84	Change n = 84
Utility (Mean, SD)	0.44 (0.37)	0.55 (0.55)	0.09 (0.27)	0.44 (0.34)	0.54 (0.31)	0.05 (0.26)
QALYs (Mean, SD)	0.12 (0.07)			0.12 (0.07)
Costs during follow-up (Mean, SD)
Outpatient	£255 (268) (n = 78)			£317 (333) (n = 82)
Primary and community care	£59 (86) (n = 75)			£66 (101) (n = 81)
Intervention	£0			£129 (n = 78)
TOTAL^a	£391 (543) (n = 75)			£552 (464) (n = 78)

^a Total cost includes inpatient admissions, day case visits, and A&E visits. The mean intervention cost is reported for participants with complete cost data. Intervention cost comprised of actual number of compression gloves provided per participant costing £31.43/glove (NHS dispensing costs) and one visit to a secondary care occupational therapist costing £65.85 (NHS reference costs)

ISSN: 1471-2474